National Veterinary Associates Appoints Medical Leadership for NVA General Practice and Ethos Veterinary Health Businesses

June 14, 2023

Dr. Sandra Faeh to serve as Chief Veterinary Officer of NVA’s General Practice business; Dr. Stacy Burdick named Chief Medical Officer of Ethos Veterinary Health. Newly created senior leadership roles position NVA General Practice and Ethos Veterinary Health for the next chapter of industry leadership as distinct veterinary businesses.

Read More
  • Partnership with VetBloom Provides Access to Veterinary Nursing Distance Learning Program

    August 9, 2019

    August 9, 2019, Woburn, MA and West Lafayette, IN: The Purdue University College of Veterinary Medicine has entered into a partnership with Ethos Veterinary Health and VetBloom, an innovative veterinary learning ecosystem, to create a pathway that allows members to earn an online veterinary nursing degree through Purdue University. The new partnership will allow VetBloom

    Read More
  • New study boasts 90% accuracy when using PARR to diagnose canine lymphoma

    August 7, 2019

    Article originally published in NEWStat, an American Animal Hospital Association Publication  Written by Tony McReynolds Who measures the measurements? Who diagnoses the diagnostics? In short, who assays the assays? Veterinarians have been using polymerase chain reaction for antigen receptor rearrangement (PARR), a readily available molecular assay that helps diagnose some kinds of canine lymphoma, for years.

    Read More
  • Lexagene’s Beta Prototype Exceeds Expectations

    July 10, 2019

    For the beta test trial, veterinarians at Mass Vet used LexaGene’s genetic analyzer to determine the cause of an infection and whether antibiotic resistance factors were present that could influence therapy decisions. They focused on processing canine and feline urine samples, but were given the opportunity to load other sample types onto the instrument such as swabs from surgical incisions, cervical swellings, and neck and chest wounds.

    Read More
  • LMU Recognizes Ethos Veterinary Health and Mass Vet as Distinguished Clinical Affiliate

    July 1, 2019

    Lincoln Memorial University-College of Veterinary Medicine recognized Ethos Veterinary Health and the Massachusetts Veterinary Referral Hospital (Mass Vet), with the Distinguished Clinical Affiliate Award in recognition of the vital role the clinical partner played in preparing LMU-CVM graduates. Dr. Beth Eisenberg, veterinary criticalist for Ethos Veterinary Health and a veterinarian for Mass Vet, accepted the award at the LMU-CVM Commencement Ceremony on May 18 in Harrogate, Tennessee.

    Read More
  • Continued Growth for Ethos Veterinary Health

    June 25, 2019

    Ethos Veterinary Health today announced the addition of two hospital groups: Wisconsin Veterinary Referral Center (WVRC), with three locations in Wisconsin, and Pet Emergency & Specialty Center of Marin (PESCM), located in San Rafael, Calif. The two entities substantially add to Ethos’ hospital network. WVRC extends Ethos’ Midwest footprint into Southern Wisconsin, and PESCM adds to Ethos’ existing presence in Northern California.

    Read More
  • Animal Hospital Readies Move to New Quarters

    June 17, 2019

    The new 17,000-square-foot hospital includes five surgery suites, 20 exam rooms, a new, 64-slice CT scanner, severe waiting rooms, a dedicated waiting room just for felines and a larger emergency facility. The animal hospital’s services will continue to include primary care, 24/7 emergency and critical care (365 days year), surgery, cardiology, internal medicine, ophthalmology, acupuncture, an exotics team and more, Bulger officials said.

    Read More
  • Bulger Veterinary Hospital Relocates

    June 12, 2019

    Bulger Veterinary Hospital Relocates to New, State-of-the-art Facility Enhancing its Ability to Care for Pets Lawrence, Mass. — June 12, 2019 – Bulger Veterinary Hospital will move to its new location at the former Showcase Cinema site in Lawrence, Massachusetts, located at 141 Winthrop Avenue in Lawrence, MA the last week of June. The move

    Read More
  • Lexagene Places its First Beta-Prototype into Massachusetts Veterinary Referral Hospital

    June 5, 2019

    LexaGene Holdings, Inc., a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today that it has placed its first beta prototype into Massachusetts Veterinary Referral Hospital (Mass Vet) in Woburn, MA. Mass Vet is an Ethos Veterinary Health hospital.

    Read More
  • TGen-Ethos Study Underscores Need for Setting High Standards in Veterinary Cancer Diagnostics

    May 21, 2019

    In a study published in the Journal of Veterinary Internal Medicine (JVIM), Ethos and TGen found that their test, called ePARR, was more than 90 percent accurate among a range of lymphoma sample types. TGen conducted genetic analysis of more than 180 dogs with naturally occurring cancer to confirm if they had lymphoma, and then determine exactly what type of lymphoma, which is a common and aggressive cancer in dogs.

    Read More
  • AAHA, VetBloom To Launch Exclusive AAHA Member Learning Platform

    April 30, 2019

    LAKEWOOD, Colorado – April 30, 2019 – In a move that brings a veterinary industry leader in online CE together with the only association to accredit companion animal hospitals in North America, VetBloom and the American Animal Hospital Association (AAHA) are excited to announce the upcoming launch of the AAHA | Learning platform. Provided as an exclusive AAHA member benefit, the new platform

    Read More
  • Ethos Veterinary Health LLC Recapitalization With Brown Brothers Harriman Capital Partners

    January 17, 2019

    Brown Brothers Harriman Completes Investment in Ethos Veterinary Health LLC New York, NY, JANUARY 9, 2019 – BBH Capital Partners (“BBHCP”) announced today that it has completed a recapitalization of Ethos Veterinary Health LLC (“Ethos” or the “Company”). Headquartered in Woburn, Massachusetts, Ethos is one of the largest pure-play independent providers of specialty veterinary health services, including 24/7

    Read More
  • First-Ever, Nationwide, Multicenter, Prospective Study Of Canine Splenic Hemangiosarcoma

    January 15, 2019

    Cutting Edge Cancer Research in Veterinary Specialty Practice: Ethos Veterinary Health Completes First-Ever, Nationwide, Multicenter, Prospective Study of Canine Splenic Hemangiosarcoma Woburn, Mass. — Jan. 15, 2019 — Ethos Veterinary Health (Ethos) has completed the patient accrual phase of their new Canine Hemangiosarcoma Molecular Profiling (CHAMP) study. Hemangiosarcoma is one of the most malignant forms of cancer in dogs and CHAMP

    Read More
Load More